Back to top

Image: Bigstock

The Cooper Companies Inc.

Read MoreHide Full Article

Cooper has outperformed its industry in a year’s time. Cooper Companies has recently acquired the assets of The LifeGlobal Group and its affiliates, bolstering its foothold in the in-vitro fertilization (IVF) devices market. Meanwhile, the CooperVision business has been delivering impressive results. A raised guidance for fiscal 2018 looks promising. Notably, Cooper Companies completed the acquisition of Paragon Vision Sciences. This added a leading ortho-k technology to the company’s lens portfolio. Considering the outstanding performance of the stock, we expect Cooper Companies to scale higher in the coming quarters. On the flipside, intense competition in the contact lens space will continue to build pricing pressure. Additionally, escalating debt levels and foreign exchange vulnerability are likely to mar the company’s bottom line. Also, the slashed revenue guidance for fiscal 2018 in CSI segment is discouraging.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


The Cooper Companies, Inc. (COO) - free report >>

Published in